The company

“Non-cystic fibrosis bronchiectasis deeply affects the lives of people living with this chronic lung condition, impacting both their…

Nutriband Inc. FDA grants meeting for AVERSA™ FENTANYL (abuse deterrent transdermal system) to provide feedback on the Chemistry,…

In April 2025, WeRide and Chery Group unveiled their jointly-developed, new generation robotaxi model, CER, at Auto Shanghai…

Soldiers marching via Shutterstock While the market has focused on the AI-driven rally in Big Tech companies such…

Mainz BioMed NV CARE currently cooperates with 19 health insurance companies in Germany in the field of colorectal…

VANCOUVER, BC, July 14, 2025 /CNW/ — Silver One Resources Inc. (TSXV: SVE) (OTCQX: SLVRF) (FSE: BRK1) (“Silver One” or…

Opus Genetics, Inc. RESEARCH TRIANGLE PARK, N.C., July 03, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD),…

XI’AN, China, July 2, 2025 /PRNewswire/ — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a…

RetinalGeniX Technologies, Inc. Cost-Efficient Methodology Aims To Reduce Reliance On Expensive Diagnostic Procedures Such As MRI, CT Scans,…

FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease